Cell alignment induced by anisotropic electrospun fibrous scaffolds alone has limited effect on cardiomyocyte maturation

Stem Cell Research

Volumn 16, Issue 3, 2016, Pages 740-750

  Han, Jingjia ^a,b   Wu, Qingling ^a,b   Xia, Younan ^b   Wagner, Mary B ^a,b   Xu, Chunhui ^a,b  

^a CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cardiomyocyte; Electrospinning; Maturation; Scaffold; Stem cell

Indexed keywords

CALCIUM; MATRIGEL; MOLECULAR SCAFFOLD; POLYCAPROLACTONE; CARDIOTONIC AGENT; POLYESTER;

ANISOTROPY; ARTICLE; CALCIUM CELL LEVEL; CARDIAC MUSCLE CELL; CELL CULTURE; CELL FUNCTION; CELL KINETICS; CELL MATURATION; CELL STRUCTURE; CONTROLLED STUDY; ELECTROSPINNING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; METABOLISM; PLURIPOTENT STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; TIME LAPSE IMAGING; TISSUE SCAFFOLD;

CALCIUM; CARDIOTONIC AGENTS; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; IMMUNOHISTOCHEMISTRY; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; POLYESTERS; REAL-TIME POLYMERASE CHAIN REACTION; TIME-LAPSE IMAGING; TISSUE SCAFFOLDS;

EID: 84964426785     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2016.04.014     Document Type: Article

References (53)

1. Barnes C.P., et al. Nanofiber technology: designing the next generation of tissue engineering scaffolds. Adv. Drug Deliv. Rev. 2007, 59:1413-1433.
2. Bashur C.A., et al. Effect of fiber diameter and orientation on fibroblast morphology and proliferation on electrospun poly(d,l-lactic-co-glycolic acid) meshes. Biomaterials 2006, 27:5681-5688.
3. Ben-David U., et al. Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells. Nat. Commun. 2013, 4:1992.
4. Bhagwati C., et al. Profile of the Chikungunya infection: a neglected vector borne disease which is prevalent in the Rajkot District. J. Clin. Diagn. Res. 2013, 7:1008-1011.
5. Bird S.D., et al. The human adult cardiomyocyte phenotype. Cardiovasc. Res. 2003, 58:423-434.
6. Birket M.J., et al. PGC-1alpha and reactive oxygen species regulate human embryonic stem cell-derived cardiomyocyte function. Stem Cell Rep. 2013, 1:560-574.
7. Burridge P.W., et al. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 2012, 10:16-28.
8. Burridge P.W., et al. Chemically defined generation of human cardiomyocytes. Nat. Methods 2014, 11:855-860.
9. Chen G., et al. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 2011, 8:424-429.
10. Chen A., et al. Integrated platform for functional monitoring of biomimetic heart sheets derived from human pluripotent stem cells. Biomaterials 2014, 35:675-683.
11. Cipitria A., Skelton A., Dargaville T.R., Dalton P.D., Hutmacher D.W. Design, fabrication and characterization of PCL electrospun scaffolds-a review. J. Mater. Chem. 2011, 21:9419-9453.
12. Clement S., et al. Expression and function of alpha-smooth muscle actin during embryonic-stem-cell-derived cardiomyocyte differentiation. J. Cell Sci. 2007, 120:229-238.
13. Chuva de Sousa Lopes S.M., et al. Patterning the heart, a template for human cardiomyocyte development. Dev. Dyn. 2006, 235:1994-2002.
14. Han J., et al. Tissue factor activity and ECM-related gene expression in human aortic endothelial cells grown on electrospun biohybrid scaffolds. Biomacromolecules 2013, 14:1338-1348.
15. Kamakura T., et al. Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circ. J. 2013, 77:1307-1314.
16. Khan M., et al. Evaluation of changes in morphology and function of human induced pluripotent stem cell derived cardiomyocytes (HiPSC-CMs) cultured on an aligned-nanofiber cardiac patch. PLoS One 2015, 10.
17. Kim D.H., et al. Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:565-570.
18. Kuroda T., et al. In vitro detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human induced pluripotent stem cells. Methods Mol. Biol. 2014, 1210:183-192.
19. Laflamme M.A., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 2007, 25:1015-1024.
20. Li R.K., et al. Human pediatric and adult ventricular cardiomyocytes in culture: assessment of phenotypic changes with passaging. Cardiovasc. Res. 1996, 32:362-373.
21. Li W.J., et al. Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J. Biomed. Mater. Res. 2002, 60:613-621.
22. Lian X., et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E1848-E1857.
23. Liau B., et al. Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials 2011, 32:9180-9187.
24. Lieu D.K., et al. Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Arrhythm. Electrophysiol. 2013, 6:191-201.
25. 2+ handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression. Am. J. Physiol. Cell Physiol. 2009, 297:C152-C159.
26. Lundy S.D., et al. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev. 2013, 22:1991-2002.
27. Ma Z., et al. Three-dimensional filamentous human diseased cardiac tissue model. Biomaterials 2014, 35:1367-1377.
28. Mandel Y., et al. Human embryonic and induced pluripotent stem cell-derived cardiomyocytes exhibit beat rate variability and power-law behavior. Circulation 2012, 125:883-893.
29. McCain M.L., et al. Micromolded gelatin hydrogels for extended culture of engineered cardiac tissues. Biomaterials 2014, 35:5462-5471.
30. Mihic A., et al. The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cell-derived cardiomyocytes. Biomaterials 2014, 35:2798-2808.
31. Mummery C.L., et al. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ. Res. 2012, 111:344-358.
32. Nguyen D.C., et al. Microscale generation of cardiospheres promotes robust enrichment of cardiomyocytes derived from human pluripotent stem cells. Stem Cell Rep. 2014, 3:260-268.
33. Nori S., et al. Long-term safety issues of iPSC-based cell therapy in a spinal cord injury model: oncogenic transformation with epithelial-mesenchymal transition. Stem Cell Rep. 2015, 4:360-373.
34. Nunes S.S., et al. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods 2013, 10:781-787.
35. Peters N.S., et al. Spatiotemporal relation between gap junctions and fascia adherens junctions during postnatal development of human ventricular myocardium. Circulation 1994, 90:713-725.
36. Pillekamp F., et al. Physiological differences between transplanted and host tissue cause functional decoupling after in vitro transplantation of human embryonic stem cell-derived cardiomyocytes. Cell. Physiol. Biochem. 2009, 23:65-74.
37. Pillekamp F., et al. Contractile properties of early human embryonic stem cell-derived cardiomyocytes: beta-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy. Stem Cells Dev. 2012, 21:2111-2121.
38. Radisic M., et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:18129-18134.
39. Rao C., et al. The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells. Biomaterials 2013, 34:2399-2411.
40. Ribeiro M.C., et al. Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro - correlation between contraction force and electrophysiology. Biomaterials 2015, 51:138-150.
41. Salick M.R., et al. Micropattern width dependent sarcomere development in human ESC-derived cardiomyocytes. Biomaterials 2014, 35:4454-4464.
42. Senel Ayaz H.G., et al. Textile-templated electrospun anisotropic scaffolds for regenerative cardiac tissue engineering. Biomaterials 2014, 35:8540-8552.
43. Tano K., et al. A novel in vitro method for detecting undifferentiated human pluripotent stem cells as impurities in cell therapy products using a highly efficient culture system. PLoS One 2014, 9.
44. Thavandiran N., et al. Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E4698-E4707.
45. Tulloch N.L., et al. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ. Res. 2011, 109:47-59.
46. Veerman C.C., et al. Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem?. Stem Cells Dev. 2015, 24:1035-1052.
47. Xiao Y., et al. Microfabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle. Lab Chip 2014, 14:869-882.
48. Xie J., et al. Conductive core-sheath nanofibers and their potential application in neural tissue engineering. Adv. Funct. Mater. 2009, 19:2312-2318.
49. Xu C., et al. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ. Res. 2002, 91:501-508.
50. Yang X., et al. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Res. 2014, 114:511-523.
51. Yu J., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
52. Zhang D., et al. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 2013, 34:5813-5820.
53. Zhao S., et al. Nanofibrous patterns by direct electrospinning of nanofibers onto topographically structured non-conductive substrates. Nanoscale 2013, 5:4993-5000.